3Brown MJ, palmer CR, Castaigne A, et al .Morbidity and mortality in patients randomized to doubleblind treatment with a long-acting calcium-channel blocker or diuretic in the international Nifedipine GITS study: intervention as a goal in hypertension treatment (Insight)[J]. Lancet ,2000,356:366-372.
4Hansson L, Lindholm LH, Niskanen L, et al .Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension :the captopril prevention project (Cappp) randomised trial [J] .Lancet ,1999,353:611-616.
5Hansson L,Hedner T, Lund johansen P, et al .Randomised trial of effects of calcium antagonists compared with diuretics and β -blockers on cardiovasvular morbidity and mortality in hypertension: the Nordic Diltiazem(Nordil) study[J].Lancet, 2000,356:359-365.
6Wikstrand J,Warnold I, Olsson C, et al . Primary prevention in patients with hypertension:comments on the clinical implications of the MAPHY study metoprolol atherosclerosis prevention in hypertensives study [J]. Am Heart J, 1998, 116 (1 pt 2):338-347.
7UK Prospective Diabetes Study Group.High blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS.38[J] . Br Med J, 1998,317:703-713.
8Hansson L, Zanchetti A ,Carruthers SG,et al. Effects of intensive blood-pressure lowering and lowdose aspirin in patients with hypertension : principal results of the Hypertension Optimal Treatment (HOT) randomised trial [J] .Lancet, 1998,351:1755-1762.
